Search Result "CpG oligodeoxynucleotides"
An Oligodeoxynucleotide with CCT Repeats Restrains CpG ODN-Induced TLR9 Trafficking
Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 9 Year: 2014 Page: 780-789
Author(s): Xiaoling Zhang,Wei Sun,Xiuli Wu,Hua Wang,Youyou Yan,Sheng Guo,Dandan Song,Hainan Li,Shuang Gao,Luowei Wang,Yongli Yu,Liying Wang
CpG Oligodeoxynucleotides: A Novel Therapeutic Approach For Atopic Disorders
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 2 Issue: 3 Year: 2003 Page: 199-205
Author(s): Iftikhar Hussain, Joel N. Kline
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Journal: Current Drug Delivery
Volume: 1 Issue: 4 Year: 2004 Page: 405-412
Author(s): Manish Diwan, Praveen Elamanchili, Min Cao, John Samuel
Suppression of HIV Replication In Vitro by CpG and CpG Conjugated to the Non Toxic B Subunit of Cholera Toxin
Journal: Current HIV Research
Volume: 6 Issue: 3 Year: 2008 Page: 230-238
Author(s): Salma Nowroozalizadeh, Marianne Jansson, Jenni Adamsson, Marianne Lindblad, Eva-Maria Fenyo, Jan Holmgren, Ali M. Harandi
Synthetic Oligodeoxynucleotides Containing Deoxycytidyl-Deoxyguanosine Dinucleotides (CpG ODNs) and Modified Analogs as Novel Anticancer Therapeutics
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 2889-2907
Author(s): H. Wang, E. Rayburn, R. Zhang
Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 230-242
Author(s): Cristina Mastini, Pablo D. Becker, Manuela Iezzi, Claudia Curcio, Piero Musiani, Guido Forni, Federica Cavallo, Carlos A. Guzman
Enhancement of Immunoprotective Effect of CpG-ODN by Formulation with Polyphosphazenes Against E. coli Septicemia in Neonatal Chickens
Journal: Current Drug Delivery
Volume: 6 Issue: 1 Year: 2009 Page: 76-82
Author(s): Azita Taghavi, Brenda Allan, George Mutwiri, Marianna Foldvari, Andrew Van Kessel, Philip Willson, Lorne Babiuk, Andrew Potter, Susantha Gomis
Toll-like Receptor 9, CpG DNA and Innate Immunity
Journal: Current Molecular Medicine
Volume: 2 Issue: 6 Year: 2002 Page: 545-556
Author(s): Ali A. Ashkar, Kenneth L. Rosenthal
Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2017 Page: 851-858
Author(s): Sahar Tahaghoghi-hajghorbani,Jalil Tavakkol-Afshari,Mahmoud Reza Jaafari,Haniyeh Ghaffari-Nazari,Elham Masoumi,Seyed Amir Jalali
Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9
Journal: Current Protein & Peptide Science
Volume: 20 Issue: 11 Year: 2019 Page: 1060-1068
Author(s): Krisztina Fehér